{"id":"hipec-with-cisplatin","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Neurotoxicity"},{"rate":null,"effect":"Gastrointestinal toxicity"},{"rate":null,"effect":"Peritoneal/abdominal complications"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"HIPEC is a regional chemotherapy technique that circulates heated cisplatin solution throughout the peritoneal cavity during surgery, allowing direct contact with peritoneal surfaces and tumor nodules while minimizing systemic exposure. The combination of hyperthermia (elevated temperature) and cisplatin enhances cytotoxic effects against cancer cells. This approach is used as an adjunctive treatment during cytoreductive surgery for peritoneal malignancies.","oneSentence":"HIPEC (hyperthermic intraperitoneal chemotherapy) with cisplatin delivers heated chemotherapy directly into the peritoneal cavity to treat intra-abdominal malignancies.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:42:34.239Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Peritoneal carcinomatosis from colorectal cancer"},{"name":"Peritoneal mesothelioma"},{"name":"Ovarian cancer with peritoneal involvement"}]},"trialDetails":[{"nctId":"NCT04847063","phase":"PHASE1","title":"Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-19","conditions":"Peritoneal Mesothelioma, Peritoneal Carcinomatosis, Ovarian Cancer","enrollment":60},{"nctId":"NCT07493421","phase":"NA","title":"To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.","status":"RECRUITING","sponsor":"Unidade Local de Saúde São João","startDate":"2026-03-01","conditions":"Pancreatic Adenocarcinoma, Peritoneal (Metastatic) Cancer","enrollment":20},{"nctId":"NCT03842982","phase":"PHASE3","title":"Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2019-05-03","conditions":"Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma","enrollment":362},{"nctId":"NCT07475286","phase":"PHASE2","title":"Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis","status":"NOT_YET_RECRUITING","sponsor":"Mohammad Haroon Asif Choudry","startDate":"2026-04-30","conditions":"Synchronous Gastric Peritoneal Carcinomatosis, Gastroesophageal Peritoneal Carcinomatosis","enrollment":22},{"nctId":"NCT07460180","phase":"PHASE1, PHASE2","title":"The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2025-05-01","conditions":"Ovarian Cancer, Epithelial Cancer, Fallopian Tube Cancer","enrollment":55},{"nctId":"NCT01970722","phase":"PHASE1","title":"Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2014-05-19","conditions":"FIGO Stage IVA Ovarian Cancer, FIGO Stage IVB Ovarian Cancer, Platinum-Resistant Ovarian Carcinoma","enrollment":40},{"nctId":"NCT05753306","phase":"PHASE2","title":"Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-04-20","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Metastatic Malignant Neoplasm in the Peritoneum","enrollment":40},{"nctId":"NCT05827523","phase":"PHASE3","title":"Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)","status":"RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2023-05-31","conditions":"Ovarian Cancer","enrollment":520},{"nctId":"NCT05415709","phase":"EARLY_PHASE1","title":"Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2022-06-13","conditions":"Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma","enrollment":45},{"nctId":"NCT07353177","phase":"","title":"Effects of HIPEC on Postoperative Bowel Motility and Complications","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-04-20","conditions":"HIPEC, Gastro Intestinal Cancer, Adhesion Prevention","enrollment":193},{"nctId":"NCT07313579","phase":"","title":"Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer","status":"RECRUITING","sponsor":"Ukrainian Society of Clinical Oncology","startDate":"2025-12-01","conditions":"Gastric Cancer (GC), HIPEC, Peritoneal Metastases From Gastric Cancer","enrollment":200},{"nctId":"NCT06839378","phase":"NA","title":"Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei","status":"COMPLETED","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2025-02-17","conditions":"Pseudomyxoma Peritonei","enrollment":36},{"nctId":"NCT07139951","phase":"PHASE2","title":"Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2025-12-03","conditions":"Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastric Cancer AJCC v8","enrollment":16},{"nctId":"NCT05659381","phase":"PHASE3","title":"Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer","status":"RECRUITING","sponsor":"GOG Foundation","startDate":"2024-03-08","conditions":"Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer","enrollment":220},{"nctId":"NCT04858009","phase":"PHASE2","title":"Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-02-15","conditions":"Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8, Metastatic Malignant Neoplasm in the Peritoneum","enrollment":40},{"nctId":"NCT04329494","phase":"PHASE1","title":"PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2020-08-21","conditions":"Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8","enrollment":49},{"nctId":"NCT07229040","phase":"PHASE2","title":"A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.","status":"RECRUITING","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2025-02-21","conditions":"Debulking Surgery for Ovarian Cancer, Acute Kidney Injury","enrollment":90},{"nctId":"NCT04107077","phase":"PHASE2","title":"Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-09-09","conditions":"Gastric Cancer, Peritoneal Carcinomatosis","enrollment":21},{"nctId":"NCT03127774","phase":"PHASE2","title":"Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma","status":"RECRUITING","sponsor":"Columbia University","startDate":"2017-09-22","conditions":"Adrenocortical Carcinoma, Peritoneal Carcinomatosis","enrollment":30},{"nctId":"NCT06057935","phase":"PHASE2","title":"A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-09-21","conditions":"Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma","enrollment":64},{"nctId":"NCT05406674","phase":"PHASE2","title":"Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2022-06-15","conditions":"FIGO Stage III Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Carcinoma","enrollment":40},{"nctId":"NCT06946901","phase":"PHASE2","title":"The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-04-03","conditions":"Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastatic Pancreatic Cancer","enrollment":90},{"nctId":"NCT01376752","phase":"PHASE3","title":"Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2011-04-26","conditions":"Ovarian Epithelial Cancer Recurrent","enrollment":415},{"nctId":"NCT05303714","phase":"PHASE3","title":"PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer","status":"RECRUITING","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2022-03-31","conditions":"Oligometastatic Gastric Adenocarcinoma","enrollment":98},{"nctId":"NCT04213794","phase":"EARLY_PHASE1","title":"Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2019-11-08","conditions":"Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm, Recurrent Colon Carcinoma","enrollment":2},{"nctId":"NCT03092518","phase":"PHASE2","title":"Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-06-05","conditions":"Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer","enrollment":27},{"nctId":"NCT04282356","phase":"PHASE2","title":"Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer","status":"RECRUITING","sponsor":"Institut du Cancer de Montpellier - Val d'Aurelle","startDate":"2020-09-15","conditions":"Ovarian Cancer, Intraperitoneal Chemotherapy","enrollment":55},{"nctId":"NCT06697613","phase":"","title":"Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2016-01-01","conditions":"Ovarian Cancer, AKI - Acute Kidney Injury","enrollment":150},{"nctId":"NCT02124421","phase":"PHASE2","title":"HOT: HIPEC in Ovarian Cancer as Initial Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mercy Medical Center","startDate":"2014-04","conditions":"Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer","enrollment":32},{"nctId":"NCT04447352","phase":"PHASE3","title":"HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)","status":"RECRUITING","sponsor":"Krankenhaus Nordwest","startDate":"2020-12-17","conditions":"Gastric Cancer, Gastroesophageal Junction Adenocarcinoma","enrollment":200},{"nctId":"NCT02891447","phase":"PHASE2","title":"Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-09-01","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis","enrollment":24},{"nctId":"NCT06544460","phase":"PHASE2","title":"Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2024-08-31","conditions":"Ovarian Cancer","enrollment":94},{"nctId":"NCT04931420","phase":"PHASE2","title":"Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2022-05-19","conditions":"Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma","enrollment":""},{"nctId":"NCT06525714","phase":"EARLY_PHASE1","title":"Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2024-08","conditions":"Gastric Cancer, Survival Rate","enrollment":302},{"nctId":"NCT06277947","phase":"NA","title":"Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-02","conditions":"Epithelial Ovarian Cancer","enrollment":92},{"nctId":"NCT02567253","phase":"PHASE2","title":"Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2016-03","conditions":"Ovarian Cancer, Primary Peritoneal Cancer","enrollment":56},{"nctId":"NCT03917173","phase":"NA","title":"Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study","status":"UNKNOWN","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2020-06-01","conditions":"Stomach Neoplasms","enrollment":240},{"nctId":"NCT06057298","phase":"NA","title":"Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC)","status":"UNKNOWN","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2021-06-15","conditions":"Peritoneal Metastases From Colorectal Cancer","enrollment":24},{"nctId":"NCT03772028","phase":"PHASE3","title":"Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2020-01-01","conditions":"Ovarian Cancer","enrollment":538},{"nctId":"NCT00968799","phase":"NA","title":"Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study","status":"TERMINATED","sponsor":"Cantonal Hospital of St. Gallen","startDate":"2008-02","conditions":"Epithelial Ovarian Cancer, Fallopian Tube Carcinoma","enrollment":6},{"nctId":"NCT02995850","phase":"PHASE1, PHASE2","title":"A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2017-02-22","conditions":"Gastric Cancer With Peritoneal Metastasis (PCI<12)","enrollment":25},{"nctId":"NCT05877911","phase":"PHASE2","title":"Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-05","conditions":"Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure","enrollment":110},{"nctId":"NCT03275194","phase":"PHASE2","title":"HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy","status":"RECRUITING","sponsor":"Instituto Nacional de Cancerologia de Mexico","startDate":"2017-09-02","conditions":"HPEC, Ovarian Cancer, Women's Health: Neoplasm of Ovary","enrollment":100},{"nctId":"NCT03330028","phase":"PHASE1","title":"Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-10-27","conditions":"Diseases of Oesophagus Stomach and Duodenum","enrollment":29},{"nctId":"NCT03321188","phase":"PHASE2","title":"Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients","status":"UNKNOWN","sponsor":"Andrea Jewell","startDate":"2017-12-15","conditions":"Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer","enrollment":20},{"nctId":"NCT05620654","phase":"PHASE1","title":"A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2022-12-01","conditions":"Ovarian Cancer, Hyperthermic Intraperitoneal Chemotherapy, Paclitaxel","enrollment":30},{"nctId":"NCT03540017","phase":"PHASE1","title":"HIPEC After Initial CRS in Patients Who Have Received NACT","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2019-03-12","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma","enrollment":15},{"nctId":"NCT05497739","phase":"PHASE2","title":"Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer","status":"UNKNOWN","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2022-06-28","conditions":"Gastric Cancer","enrollment":68},{"nctId":"NCT03604653","phase":"","title":"Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers","status":"COMPLETED","sponsor":"Holy Name Medical Center, Inc.","startDate":"2018-05-15","conditions":"Stomach Cancer, Colorectal Cancer, Appendiceal Cancer","enrollment":10},{"nctId":"NCT02475772","phase":"PHASE1","title":"A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis","status":"COMPLETED","sponsor":"Clemens Tempfer","startDate":"2016-11","conditions":"Ovarian Cancer","enrollment":15},{"nctId":"NCT03717610","phase":"NA","title":"Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer","status":"UNKNOWN","sponsor":"Uppsala University Hospital","startDate":"2018-10-04","conditions":"Ovarian Cancer Recurrent","enrollment":10},{"nctId":"NCT02158988","phase":"PHASE3","title":"Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2014-03-01","conditions":"Malignant Neoplasm of Stomach, Secondary Malignant Neoplasm of Peritoneum, Secondary Malignant Neoplasm of Other and Unspecified Sites","enrollment":105},{"nctId":"NCT02092298","phase":"PHASE2","title":"Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-05-08","conditions":"Gastrointestinal Cancer","enrollment":21},{"nctId":"NCT02830139","phase":"PHASE2","title":"Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer","status":"COMPLETED","sponsor":"Wuhan University","startDate":"2016-07","conditions":"Malignant Neoplasm of Colorectum","enrollment":100},{"nctId":"NCT01091636","phase":"PHASE2, PHASE3","title":"Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer","status":"COMPLETED","sponsor":"National Cancer Center, Korea","startDate":"2010-03","conditions":"Epithelial Ovarian Cancer","enrollment":184},{"nctId":"NCT01277744","phase":"PHASE2","title":"Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-05-09","conditions":"Advanced Cancers, Sarcoma","enrollment":22},{"nctId":"NCT03373058","phase":"PHASE3","title":"Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery","status":"UNKNOWN","sponsor":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","startDate":"2019-10-15","conditions":"Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma","enrollment":310},{"nctId":"NCT03220932","phase":"PHASE3","title":"Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2019-11-30","conditions":"Ovarian Epithelial Cancer","enrollment":132},{"nctId":"NCT03210298","phase":"","title":"International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)","status":"UNKNOWN","sponsor":"Sabine Rhode","startDate":"2016-01","conditions":"Peritoneum Cancer, Peritoneum Neoplasm, Pleural Cancer","enrollment":1000},{"nctId":"NCT03023436","phase":"PHASE3","title":"Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2016-01","conditions":"Stomach Neoplasm","enrollment":220},{"nctId":"NCT01833832","phase":"PHASE2","title":"Surgery and Heated Chemotherapy for Adrenocortical Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-04-12","conditions":"Adrenocortical Carcinoma, Peritoneal Carcinomatosis","enrollment":11},{"nctId":"NCT03150628","phase":"PHASE2","title":"Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study","status":"TERMINATED","sponsor":"Richard van Hillegersberg","startDate":"2017-08-01","conditions":"Gastric Cancer, Peritoneal Carcinomatosis, HIPEC","enrollment":3},{"nctId":"NCT02949791","phase":"PHASE2","title":"HIPEC Using High Intra-abdominal Pressure","status":"COMPLETED","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2014-12","conditions":"Pseudomyxoma Peritonei, Colorectal Cancer","enrollment":38},{"nctId":"NCT01683864","phase":"PHASE2, PHASE3","title":"Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer","status":"TERMINATED","sponsor":"University Hospital Tuebingen","startDate":"2012-09","conditions":"Gastric Cancer, Peritoneal Carcinomatosis","enrollment":3},{"nctId":"NCT03180177","phase":"PHASE3","title":"Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer","status":"UNKNOWN","sponsor":"Shu-Zhong Cui","startDate":"2018-03-01","conditions":"Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma","enrollment":263},{"nctId":"NCT02328716","phase":"PHASE3","title":"Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma","status":"UNKNOWN","sponsor":"Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia","startDate":"2012-02","conditions":"Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma","enrollment":32},{"nctId":"NCT03179579","phase":"PHASE3","title":"Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer","status":"UNKNOWN","sponsor":"Shu-Zhong Cui","startDate":"2017-08-01","conditions":"Gastric Cancer, Peritoneal Carcinomatosis","enrollment":88},{"nctId":"NCT01659554","phase":"PHASE2","title":"A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers","status":"TERMINATED","sponsor":"Columbia University","startDate":"2012-03","conditions":"Recurrent Ovarian Cancer, Fallopian Tube Cancer","enrollment":4},{"nctId":"NCT03034850","phase":"","title":"Thrombin Generation and Platelet Activation in CRS/HIPEC","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2015-04","conditions":"Mesothelioma; Peritoneum, Pseudomyxoma Peritonei, Peritoneal Carcinomatosis","enrollment":27},{"nctId":"NCT01709487","phase":"PHASE1, PHASE2","title":"Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy","status":"COMPLETED","sponsor":"Jules Bordet Institute","startDate":"2010-05","conditions":"Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma","enrollment":19},{"nctId":"NCT02217956","phase":"PHASE1","title":"Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2011-06","conditions":"Ovarian Adenocarcinoma, Fallopian Tube Adenocarcinoma, Primary Peritoneal Carcinoma","enrollment":30},{"nctId":"NCT02575859","phase":"PHASE1, PHASE2","title":"Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients","status":"COMPLETED","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2006-01","conditions":"Colorectal Neoplasm, Metastasis","enrollment":20},{"nctId":"NCT02396498","phase":"PHASE3","title":"SP Intravenous Chemotherapy Versus SP by HIPEC in Stage Ⅲ Patients After D2 Gastrectomy","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2014-04","conditions":"Stage Ⅲ Gastric Cancer","enrollment":270},{"nctId":"NCT02381847","phase":"PHASE3","title":"Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2015-01","conditions":"Malignant Neoplasm of Stomach","enrollment":60},{"nctId":"NCT02291211","phase":"PHASE2","title":"S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis","status":"UNKNOWN","sponsor":"Tang-Du Hospital","startDate":"2014-09","conditions":"Stage IV Gastric Cancer","enrollment":60},{"nctId":"NCT01628380","phase":"PHASE3","title":"Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian Cancer","status":"UNKNOWN","sponsor":"A.O. Ospedale Papa Giovanni XXIII","startDate":"2012-06","conditions":"Ovarian Neoplasms","enrollment":94},{"nctId":"NCT01539785","phase":"NA","title":"Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence","status":"UNKNOWN","sponsor":"Catholic University of the Sacred Heart","startDate":"2012-09","conditions":"First Recurrence of Ovarian Cancer","enrollment":158},{"nctId":"NCT01379482","phase":"PHASE2","title":"Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2005-01","conditions":"Peritoneal Carcinomatosis, Gastric Cancer","enrollment":18},{"nctId":"NCT01387399","phase":"PHASE1","title":"Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer","status":"UNKNOWN","sponsor":"University Hospital, Bonn","startDate":"2011-06","conditions":"Ovarian Cancer","enrollment":9},{"nctId":"NCT00052962","phase":"PHASE3","title":"Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2003-01","conditions":"Gastrointestinal Neoplasm","enrollment":30},{"nctId":"NCT00454519","phase":"PHASE2","title":"Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis","status":"UNKNOWN","sponsor":"Wuhan University","startDate":"2007-03","conditions":"Stomach Neoplasms, Colorectal Neoplasms, Neoplasm Metastasis","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Hipec with Cisplatin","genericName":"Hipec with Cisplatin","companyName":"Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia","companyId":"fundacion-para-la-formacion-e-investigacion-sanitarias-de-la-region-de-murcia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"HIPEC (hyperthermic intraperitoneal chemotherapy) with cisplatin delivers heated chemotherapy directly into the peritoneal cavity to treat intra-abdominal malignancies. Used for Peritoneal carcinomatosis from colorectal cancer, Peritoneal mesothelioma, Ovarian cancer with peritoneal involvement.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}